Full Fed. Circ. Told Patents Can't Render Themselves Obvious
Persion Pharmaceuticals is asking the full Federal Circuit to revive claims of two patents covering its opioid painkiller Zohydro ER, saying the panel upheld contradictory analyses and used the patents' own specifications...To view the full article, register now.
Already a subscriber? Click here to view full article